# A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning

> **NCT02410525** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [11C]PF-06427878
- **DRUG:** PF-06427878 10 mg
- **DRUG:** PF-06427878 600 mg

## Key facts

- **NCT ID:** NCT02410525
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02410525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02410525, "A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02410525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*